CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 132 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $764,050 | -71.9% | 35,000 | -68.6% | 0.00% | -75.0% |
| Q1 2023 | $2,717,046 | -78.6% | 111,400 | -72.4% | 0.01% | -81.4% |
| Q4 2022 | $12,714,689 | -58.5% | 403,129 | -62.8% | 0.04% | -64.8% |
| Q3 2022 | $30,641,000 | +472.8% | 1,084,240 | +436.0% | 0.12% | +430.4% |
| Q2 2022 | $5,349,000 | +28.2% | 202,300 | +43.1% | 0.02% | +27.8% |
| Q3 2021 | $4,171,000 | -55.8% | 141,400 | -61.6% | 0.02% | -57.1% |
| Q2 2021 | $9,442,000 | +131.8% | 368,550 | +24.2% | 0.04% | +121.1% |
| Q1 2021 | $4,074,000 | +104.7% | 296,700 | +147.2% | 0.02% | +90.0% |
| Q4 2020 | $1,990,000 | – | 120,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |